Literature DB >> 18005680

A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86.

Ashutosh Chaudhry1, Suman Ranjan Das, Shahid Jameel, Anna George, Vineeta Bal, Satyajit Mayor, Satyajit Rath.   

Abstract

The Nef protein of HIV-1 mediates immune evasion by relocating major histocompatibility complex (MHC) molecules and the immune costimulatory molecules CD80 and CD86 away from the monocytic cell surface. We describe a two-pronged mechanism by which Nef removes CD80 and CD86 from the cell surface. While MHCI, CD80, and CD86 are all internalized via a dynamin-independent pathway, the endocytic mechanism used for costimulatory molecules is distinct from MHCI relocation. Nef expression results in the activation and actin-dependent translocation of Src kinase to the cell periphery. At the cell surface, Src promotes Rac activation via TIAM, a guanine nucleotide exchange factor for Rac. Nef also binds to the cytosolic tails of CD80 and CD86, triggering their endocytosis via Rac-based actin polymerization. These data reveal the use of an unusual molecular mechanism triggered in the host cell by HIV to affect its viral immune evasion strategy and suggest approaches for its subversion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005680     DOI: 10.1016/j.chom.2007.01.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  20 in total

1.  HIV-1 Nef binds a subpopulation of MHC-I throughout its trafficking itinerary and down-regulates MHC-I by perturbing both anterograde and retrograde trafficking.

Authors:  Ling Yi; Tilman Rosales; Jeremy J Rose; Bhabadeb Chowdhury; Bhabhadeb Chaudhury; Jay R Knutson; Sundararajan Venkatesan
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

2.  Nicotinic acetylcholine receptor is internalized via a Rac-dependent, dynamin-independent endocytic pathway.

Authors:  Sudha Kumari; Virginia Borroni; Ashutosh Chaudhry; Baron Chanda; Ramiro Massol; Satyajit Mayor; Francisco J Barrantes
Journal:  J Cell Biol       Date:  2008-06-30       Impact factor: 10.539

3.  HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements.

Authors:  Jolie A Leonard; Tracy Filzen; Christoph C Carter; Malinda Schaefer; Kathleen L Collins
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

4.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

Review 5.  Rho'ing in and out of cells: viral interactions with Rho GTPase signaling.

Authors:  Céline Van den Broeke; Thary Jacob; Herman W Favoreel
Journal:  Small GTPases       Date:  2014-03-24

6.  Clathrin-independent pathways of endocytosis.

Authors:  Satyajit Mayor; Robert G Parton; Julie G Donaldson
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

7.  Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.

Authors:  Andrey Tokarev; John Guatelli
Journal:  Cell Logist       Date:  2011-05

8.  HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins.

Authors:  Claudia Haller; Birthe Müller; Joëlle V Fritz; Miguel Lamas-Murua; Bettina Stolp; François M Pujol; Oliver T Keppler; Oliver T Fackler
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation.

Authors:  Amjad Hussain; Clement Wesley; Mohammad Khalid; Ashutosh Chaudhry; Shahid Jameel
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems.

Authors:  Jamie I MacPherson; Jonathan E Dickerson; John W Pinney; David L Robertson
Journal:  PLoS Comput Biol       Date:  2010-07-29       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.